Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1989;79:674-686

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Davidenko, J. M.
Right arrow Articles by Antzelevitch, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davidenko, J. M.
Right arrow Articles by Antzelevitch, C.

Circulation, Vol 79, 674-686, Copyright © 1989 by American Heart Association


ARTICLES

Quinidine-induced action potential prolongation, early afterdepolarizations, and triggered activity in canine Purkinje fibers. Effects of stimulation rate, potassium, and magnesium

JM Davidenko, L Cohen, R Goodrow and C Antzelevitch
Masonic Medical Research Laboratory, Utica, New York 13504.

Early afterdepolarization (EAD)-induced triggered activity is thought to contribute to the cardiac arrhythmogenic effects of several class I antiarrhythmic agents. The combination of quinidine therapy, bradycardia, and hypokalemia is known to predispose to torsade de pointes, which is a form of atypical polymorphous ventricular tachycardia commonly associated with long QT intervals. Recent clinical reports have shown suppression of quinidine-induced torsade de pointes with intravenous administration of magnesium sulfate. To provide further understanding of these relations, we used standard microelectrode techniques to examine the time course of quinidine- induced action potential prolongation, EAD, and triggered activity development and the dependence of these changes on [K+]0, [Mg2+]0, and stimulation frequency in isolated Purkinje fiber preparations exposed to low concentrations of the drug. At slow stimulation rates, the quinidine-induced increase of action potential duration was slow to develop and failed to reach a steady state after 3 hours of exposure to the drug. EAD and EAD-induced triggered activity generally became apparent 70-90 minutes after adding the drug. Quinidine produced triggered activity in 10 of 22 preparations superfused with Tyrode's solution containing normal [K+]0 (3.5-4.0 mM) and in six other preparations when [K+]0 was reduced. In the presence of normal [K+]0, two types of EAD and triggered activity were distinguished. In four of 10 preparations, this activity arose from phase 2 of the action potential; in eight of 10, it was associated with phase 3; and in two experiments, both types were present in the same preparation. The incidence of both forms of triggered responses depended greatly on the rate of stimulation. Triggered activity arising from phase 3 was always manifest at rates considerably slower than those giving rise to phase 2 activity. Both forms of triggered activity were sensitive to changes in the extracellular concentration of potassium and magnesium. Lower-than- normal levels of these electrolytes facilitated the manifestation of triggered activity, whereas elevated levels suppressed or caused a shift in the frequency-dependence of the activity. Phase 2, but not phase 3, EADs were abolished in response to increased [Mg2+]0. The data show a clear congruity between the conditions that predispose to torsade de pointes in the clinic and the conditions under which quinidine may induce triggered activity and marked action potential prolongation in isolated Purkinje fibers.(ABSTRACT TRUNCATED AT 400 WORDS)


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Poelzing and R. Veeraraghavan
Heterogeneous ventricular chamber response to hypokalemia and inward rectifier potassium channel blockade underlies bifurcated T wave in guinea pig
Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H3043 - H3051.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
C. Antzelevitch, L. Belardinelli, L. Wu, H. Fraser, A. C. Zygmunt, A. Burashnikov, J. M. Di Diego, J. M. Fish, J. M. Cordeiro, R. J. Goodrow Jr, et al.
Electrophysiologic Properties and Antiarrhythmic Actions of a Novel Antianginal Agent
Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2004; 9(1_suppl): S65 - S83.
[Abstract] [PDF]


Home page
Eur Heart JHome page
T. Noda, H. Takaki, T. Kurita, K. Suyama, N. Nagaya, A. Taguchi, N. Aihara, S. Kamakura, K. Sunagawa, K. Nakamura, et al.
Gene-specific response of dynamic ventricular repolarization to sympathetic stimulation in LQT1, LQT2 and LQT3 forms of congenital long QT syndrome
Eur. Heart J., June 2, 2002; 23(12): 975 - 983.
[Abstract] [Full Text] [PDF]


Home page
Hum Exp ToxicolHome page
A P Beelen, K-T. Yeo, and L D Lewis
Asymptomatic QTc prolongation associated with quetiapine fumarate overdose in a patient being treated with risperidone
Human and Experimental Toxicology, April 1, 2001; 20(4): 215 - 219.
[Abstract] [PDF]


Home page
Toxicol SciHome page
K. Yamamoto, T. Tamura, R. Imai, and M. Yamamoto
Acute Canine Model for Drug-Induced Torsades de Pointes in Drug Safety Evaluation--Influences of Anesthesia and Validation with Quinidine and Astemizole
Toxicol. Sci., March 1, 2001; 60(1): 165 - 176.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. F. Spear and E. N. Moore
Modulation of arrhythmias by isoproterenol in a rabbit heart model of d-sotalol-induced long Q-T intervals
Am J Physiol Heart Circ Physiol, July 1, 2000; 279(1): H15 - H25.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. Lacroix, F. Extramiana, P. Delfaut, M. Adamantidis, D. Grandmougin, D. Klug, S. Kacet, and B. Dupuis
Factors affecting epicardial dispersion of repolarization: a mapping study in the isolated porcine heart
Cardiovasc Res, March 1, 1999; 41(3): 563 - 574.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. Eckardt, W. Haverkamp, M. Borggrefe, and G. Breithardt
Experimental models of torsade de pointes
Cardiovasc Res, July 1, 1998; 39(1): 178 - 193.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W. Shimizu, T. Kurita, K. Matsuo, K. Suyama, N. Aihara, S. Kamakura, J. A. Towbin, and K. Shimomura
Improvement of Repolarization Abnormalities by a K+ Channel Opener in the LQT1 Form of Congenital Long-QT Syndrome
Circulation, April 28, 1998; 97(16): 1581 - 1588.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. F. Spear and E. N. Moore
Modulation of quinidine-induced arrhythmias by temperature in perfused rabbit heart
Am J Physiol Heart Circ Physiol, March 1, 1998; 274(3): H817 - H828.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Nattel
Experimental evidence for proarrhythmic mechanisms of antiarrhythmic drugs
Cardiovasc Res, March 1, 1998; 37(3): 567 - 577.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. Dumaine and G. E. Kirsch
Mechanism of lidocaine block of late current in long Q-T mutant Na+ channels
Am J Physiol Heart Circ Physiol, February 1, 1998; 274(2): H477 - H487.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
A. A. Grace and A. J. Camm
Quinidine
N. Engl. J. Med., January 1, 1998; 338(1): 35 - 45.
[Full Text] [PDF]


Home page
CirculationHome page
E. A. Sosunov, E. P. Anyukhovsky, and M. R. Rosen
Effects of Quinidine on Repolarization in Canine Epicardium, Midmyocardium, and Endocardium : I. In Vitro Study
Circulation, December 2, 1997; 96(11): 4011 - 4018.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
S.C. Verduyn, M.A. Vos, J. van der Zande, F.F. van der Hulst, and H.J. Wellens
Role of interventricular dispersion of repolarization in acquired torsade-de-pointes arrhythmias: reversal by magnesium
Cardiovasc Res, June 1, 1997; 34(3): 453 - 463.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
A. Lukas
Electrophysiology of Myocardial Cells in the Epicardial, Midmyocardial, and Endocardial Layers of the Ventricle
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1997; 2(1): 61 - 72.
[Abstract] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
C. Takanaka, K. O. Ogunyankin, J.S.M. Sarma, and B. N. Singh
Antiarrhythmic and Arrhythmogenic Actions of Varying Levels of Extracellular Magnesium: Possible Cellular Basis for the Differences in the Efficacy of Magnesium and Lidocaine in Torsade de Pointes
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1997; 2(2): 125 - 134.
[Abstract] [PDF]


Home page
Circ. Res.Home page
N. El-Sherif, E. B. Caref, H. Yin, and M. Restivo
The Electrophysiological Mechanism of Ventricular Arrhythmias in the Long QT Syndrome: Tridimensional Mapping of Activation and Recovery Patterns
Circ. Res., September 1, 1996; 79(3): 474 - 492.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
R. Dumaine, Q. Wang, M. T. Keating, H. A. Hartmann, P. J. Schwartz, A. M. Brown, and G. E. Kirsch
Multiple Mechanisms of Na+ Channel– Linked Long-QT Syndrome
Circ. Res., May 1, 1996; 78(5): 916 - 924.
[Abstract] [Full Text]


Home page
CirculationHome page
C. F. Starmer, D. N. Romashko, R. S. Reddy, Y. I. Zilberter, J. Starobin, A. O. Grant, and V. I. Krinsky
Proarrhythmic Response to Potassium Channel Blockade : Numerical Studies of Polymorphic Tachyarrhythmias
Circulation, August 1, 1995; 92(3): 595 - 605.
[Abstract] [Full Text]